New centre fuels drug discovery at Monash
A new cutting-edge research training platform to produce the drug discovery research leaders of the future was launched at Monash University today.
Combination antibiotic treatments found to reduce mortality for superbug infections
New research from Monash University, in collaboration with the University of North Carolina at Chapel Hill, could change the way patients with life-threatening drug-resistant infections across the world are treated.
MIPS and Thermo Fisher announce ‘GPCR Cryo-EM and Drug Design’ collaboration
A new collaboration between MIPS researcher Professor Patrick Sexton’s team and the leading biological cryo-EM biotechnology product development company, Thermo Fisher Scientific, will bring cryo-electron microscopy of G protein-coupled
Weaning ourselves off opioids: Monash researchers use nanotechnology for pain relief
Researchers at the Monash Institute of Pharmaceutical Sciences (MIPS) and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CBNS) have created a nanoparticle that could improve the properties of painkillers by delivering
CMUS partners with Austin Health on an exclusive PhD opportunity
The Centre for Medicine Use and Safety (CMUS) is partnering with Austin Health to offer a suitably qualified pharmacist the opportunity to undertake PhD research on use of electronic medical record data to optimise medicines use.
Old fashioned may be the safest bet: Monash researchers find that paracetamol works best for pain relief
Research by the Centre for Medicine Use and Safety at Monash University in collaboration with the Department of Emergency Medicine, Auckland Hospital in New Zealand has found that paracetamol alone is just as effective as combining opioids and
A/Prof Joe Nicolazzo receives IMPACT grant from FIGHTMND
FightMND has announced a major funding commitment to advance research into Motor Neurone Disease as the fight to find effective treatments and a cure for the disease continues.
Monash researchers uncover new potential treatment for diabetes and obesity
- An international study, led by Monash University, has uncovered an experimental drug that could treat obesity, diabetes and loss of muscle mass in the future.
- A compound called IC7Fc could improve glucose metabolism and prevent
MIPS maintains top score in 2018 ERA rankings
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.